目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Age Group
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Prediabetes Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis

Chapter 4. Prediabetes Market: Drug Class Business Analysis
4.1. Drug Class Market Share, 2024 & 2030
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, By Drug Class, 2018 to 2030 (USD Million)
4.4. Diguanide
4.4.1. Diguanide Market, 2018 - 2030 (USD Million)
4.5. Thiazolidinediones
4.5.1. Thiazolidinediones Market, 2018 - 2030 (USD Million)
4.6. Glucagon-like peptide-1 agonists (GLP-1)
4.6.1. Glucagon-like peptide-1 agonists (GLP-1) Market, 2018 - 2030 (USD Million)
4.7. SGLT2 inhibitors
4.7.1. SGLT2 inhibitors Market, 2018 - 2030 (USD Million)
4.8. DPP-4 inhibitors
4.8.1. DPP-4 inhibitors Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Prediabetes Market: Age Group Business Analysis
5.1. Age Group Market Share, 2024 & 2030
5.2. Age Group Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, By Age Group, 2018 to 2030 (USD Million)
5.4. Children (12-18 years)
5.4.1. Children (12-18 years) Market, 2018 - 2030 (USD Million)
5.5. Adults (18-49)
5.5.1. Adults (18-49) Market, 2018 - 2030 (USD Million)
5.6. Elderly (50+)
5.6.1. Elderly (50+) Market, 2018 - 2030 (USD Million)

Chapter 6. Prediabetes Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.4. North America
6.4.1. North America Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamic
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamic
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamic
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamic
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamic
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamic
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamic
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamic
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamic
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Norway
6.5.8.1. Key Country Dynamic
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Norway Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamic
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamic
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamic
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamic
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamic
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamic
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamic
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamic
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamic
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamic
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamic
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamic
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamic
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Prediabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Novo Nordisk A/S
7.5.1.1. Participant’s Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Valbiotis
7.5.2.1. Participant’s Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. RESVERLOGIX
7.5.3.1. Participant’s Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Caelus Health
7.5.4.1. Participant’s Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Scimar
7.5.5.1. Participant’s Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Boston Pharmaceuticals
7.5.6.1. Participant’s Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. APHAIA PHARMA AG
7.5.7.1. Participant’s Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. AstraZeneca
7.5.8.1. Participant’s Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Bristol-Myers Squibb Company
7.5.9.1. Participant’s overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Pfizer Inc.
7.5.10.1. Participant’s Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Prediabetes Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 5 Global Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 6 North America Prediabetes Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 8 North America Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 9 U.S. Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 10 U.S. Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 11 Canada Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 12 Canada Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 13 Mexico Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 14 Mexico Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 15 Europe Prediabetes Market, by Country, 2018 - 2030 (USD Million)
Table 16 Europe Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 17 Europe Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 18 U.K. Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 19 U.K. Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 20 Germany Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 21 Germany Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 22 France Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 23 France Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 24 Italy Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 25 Italy Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 26 Spain Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 27 Spain Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 28 Denmark Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 29 Denmark Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 30 Norway Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 31 Norway Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 32 Sweden Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 33 Sweden Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Prediabetes Market, by Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 37 Japan Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 38 Japan Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 39 China Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 40 China Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 41 India Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 42 India Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 43 South Korea Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 44 South Korea Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 45 Australia Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 46 Australia Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 47 Thailand Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 48 Thailand Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 49 Latin America Prediabetes Market, by Country, 2018 - 2030 (USD Million)
Table 50 Latin America Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 51 Latin America Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 52 Brazil Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 53 Brazil Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 54 Argentina Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 55 Argentina Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Prediabetes Market, by Country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 59 South Africa Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 60 South Africa Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 63 UAE Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 64 UAE Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)
Table 65 Kuwait Prediabetes Market, by Drug Class, 2018 - 2030 (USD Million)
Table 66 Kuwait Prediabetes Market, by Age Group, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Prediabetes Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 Market Formulation & Validation
Fig. 8 Market Snapshot
Fig. 9 Drug Class and Age Group Outlook (USD Million)
Fig. 10 Competitive Landscape
Fig. 11 Prediabetes Market Dynamics
Fig. 12 Prediabetes Market: Porter’s Five Forces Analysis
Fig. 13 Prediabetes Market: PESTLE Analysis
Fig. 14 Prediabetes Market: Drug Class Segment Dashboard
Fig. 15 Prediabetes Market: Drug Class Market Share Analysis, 2024 & 2030
Fig. 16 Diguanide Market, 2018 - 2030 (USD Million)
Fig. 17 Thiazolidinediones Market, 2018 - 2030 (USD Million)
Fig. 18 Glucagon-like peptide-1 agonists (GLP-1) Market, 2018 - 2030 (USD Million)
Fig. 19 SGLT2 Inhibitors Market, 2018 - 2030 (USD Million)
Fig. 20 DPP-4 Inhibitors Market, 2018 - 2030 (USD Million)
Fig. 21 Others Market, 2018 - 2030 (USD Million)
Fig. 22 Prediabetes Market: Age Group Segment Dashboard
Fig. 23 Prediabetes Market: Age Group Market Share Analysis, 2024 & 2030
Fig. 24 Children (12-18 years) Market, 2018 - 2030 (USD Million)
Fig. 25 Adults (18-49) Market, 2018 - 2030 (USD Million)
Fig. 26 Elderly (50+) Market, 2018 - 2030 (USD Million)
Fig. 27 Prediabetes Market Revenue, By Region
Fig. 28 Regional Marketplace: Key Takeaways
Fig. 29 Regional Marketplace: Key Takeaways
Fig. 30 North America Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 31 U.S. Country Dynamics
Fig. 32 U.S. Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 33 Canada Country Dynamics
Fig. 34 Canada Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 35 Mexico Country Dynamics
Fig. 36 Mexico Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 37 Europe Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 38 UK Country Dynamics
Fig. 39 UK Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Country Dynamics
Fig. 41 Germany Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 42 France Country Dynamics
Fig. 43 France Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 44 Italy Country Dynamics
Fig. 45 Italy Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 46 Spain Country Dynamics
Fig. 47 Spain Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 48 Denmark Country Dynamics
Fig. 49 Denmark Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 50 Norway Country Dynamics
Fig. 51 Norway Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 52 Sweden Country Dynamics
Fig. 53 Sweden Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 55 Japan Country Dynamics
Fig. 56 Japan Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 57 China Country Dynamics
Fig. 58 China Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 59 India Country Dynamics
Fig. 60 India Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 61 South Korea Country Dynamics
Fig. 62 South Korea Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 63 Australia Country Dynamics
Fig. 64 Australia Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 65 Thailand Country Dynamics
Fig. 66 Thailand Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 67 Latin America Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 68 Brazil Country Dynamics
Fig. 69 Brazil Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 70 Argentina Country Dynamics
Fig. 71 Argentina Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 72 Middle East & Africa Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 73 South Africa Country Dynamics
Fig. 74 South Africa Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia Country Dynamics
Fig. 76 Saudi Arabia Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 77 UAE Country Dynamics
Fig. 78 UAE Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait Key Country Dynamics
Fig. 80 Kuwait Prediabetes Market, 2018 - 2030 (USD Million)
Fig. 81 Company Categorization
Fig. 82 Company Market Position Analysis
Fig. 83 Strategic Framework